SCHEMBL20208745

SCHEMBL20208745

CN(C/C=C/c1cccc(F)c1)Cc1coc2ccccc12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.65
CYP1A2 P05177 1/20 0.65
CYP3A4 P08684 1/20 0.65
CYP2C8 P10632 1/20 0.65
CYP2D6 P10635 1/20 0.65
CYP2C9 P11712 1/20 0.65
CYP2B6 P20813 1/20 0.65
CYP2C19 P33261 1/20 0.65
NR1I2 O75469 1/20 0.50
DRD2 P14416 1/20 0.50
ADRA2C P18825 1/20 0.50
CNR1 P21554 1/20 0.50
SLC6A2 P23975 1/20 0.50
HTR2A P28223 1/20 0.50
SLC6A4 P31645 1/20 0.50
ADRA1A P35348 1/20 0.50
OPRK1 P41145 1/20 0.50
SLC6A3 Q01959 1/20 0.50
EBP Q15125 1/20 0.50
SIGMAR1 Q99720 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20209115 0.87 CYP1A2 (0.67) KCNH2CYP1A2CYP3A4CYP2C8CYP2D6
SCHEMBL20209110 0.87 KCNH2 (0.77) KCNH2CYP1A2CYP3A4CYP2C8CYP2D6
SCHEMBL20209368 0.87 CYP1A2 (0.84) KCNH2CYP1A2CYP3A4CYP2C8CYP2D6
SCHEMBL20208591 0.86 CYP1A2 (0.65) KCNH2CYP1A2CYP3A4CYP2C8CYP2D6
SCHEMBL20208664 0.86 CYP1A2 (0.62) KCNH2CYP1A2CYP3A4CYP2C8CYP2D6
SCHEMBL20208593 0.84 KCNH2 (0.63) KCNH2CYP1A2CYP3A4CYP2C8CYP2D6
SCHEMBL20209112 0.83 CYP1A2 (0.70) KCNH2CYP1A2CYP3A4CYP2C8CYP2D6
SCHEMBL20208909 0.82 CYP1A2 (0.62) KCNH2CYP1A2CYP3A4CYP2C8CYP2D6
SCHEMBL20208759 0.82 KCNH2 (0.62) KCNH2CYP1A2CYP3A4CYP2C8CYP2D6
SCHEMBL20209137 0.82 KCNH2 (0.60) KCNH2CYP1A2CYP3A4CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829464-B2 Benzoheterocyclic alkylamine compounds and use thereof EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2020-11-10 US disclosed
US-20190315703-A1 BENZOHETEROCYCLIC ALKYLAMINE COMPOUNDS AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-10-17 US disclosed
EP-3546454-A1 BENZOHETEROCYCLYL ALKYLAMINE COMPOUND AND USE THEREOF East China University of Science and Technology (CN) 2019-10-02 EP disclosed
WO-2018095287-A1 BENZOHETEROCYCLYL ALKYLAMINE COMPOUND AND USE THEREOF 华东理工大学 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829464-B2 Benzoheterocyclic alkylamine compounds and use thereof AADAC, AAAS, NISCH KCNH2 901/4885CYP1A2 1004/4885CYP3A4 1833/4885
US-20190315703-A1 BENZOHETEROCYCLIC ALKYLAMINE COMPOUNDS AND USE THEREOF AADAC, AAAS, NISCH KCNH2 901/4885CYP1A2 1004/4885CYP3A4 1833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.